Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Roslin scientists join efforts to tackle COVID-19
The novel disease is named COVID-19 and the virus is SARS-CoV-2.

Insights could lead to new strategies to control virus spread

Scientists at the Roslin Institute are participating in the global effort to better understand and develop treatments for the ongoing COVID-19 outbreak.


Using publicly-available genetic information, researchers are investigating the similarities between the novel virus (formally named SARS-CoV-2), severe acute respiratory syndrome (SARS- CoV) and related bat viruses.


The team says the comparisons are already helping them to identify genetic regions of the virus that may be changing in response to human infections, and could lead to new control strategies.

A global effort


Many organisations in countries affected by COVID-19 have performed rapid whole-genome sequencing of the virus and shared their results via scientific databases. This allows researchers, no matter where they based, to study the information immediately.


Scientists are trying to ascertain when and how COVID-19 first passed from an animal to a human. With this information, they can then explore what factors enabled the virus to spread. 


‘Currently, the genetic details of novel coronavirus samples from humans are very similar to each other,’ the scientists said. ‘They differ by only a few variations in the genetic code across the whole sequence of about 30,000 letters of DNA.

'This indicates that there has been a relatively short time since the disease originally emerged in humans for changes in the genetic code to accumulate. The approximate time of emergence can be estimated using the sequence data. This is done by looking at how and where the virus spreads, as well as how it evolves.’

Steroids ‘provide little benefit’


Scientists at the University of Edinburgh have concluded that, based on evidence from previous outbreaks, such as SARS, treating coronavirus patients with steroids ‘provides little benefit and could do more harm than good’.

‘Steroids impair the immune system’s ability to fight viruses and other infections that often develop in patients with a life-threatening illness,' the researchers said.

‘Patients with MERS or SARS who were treated with steroids seemed to take longer to clear the infection from their bodies, but the evidence is not clear and clinical trials will be needed to be sure.’

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.